(Q33343743)

English

Dose-escalation study of weekly irinotecan and daily carboplatin with concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dose-escalation study of weekly irinotecan and daily carboplatin with concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

M Yamada

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

S Kudoh

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

H Fukuda

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

K Nakagawa

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

N Yamamoto

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Y Nishimura

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

S Negoro

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

K Takeda

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

M Tanaka

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

M Fukuoka

10

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

1 July 2002

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

87

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

258-263

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Phase I/IIa study of concurrent paclitaxel and cisplatin with radiation therapy in locally advanced non-small cell lung cancer: analysis of early and late pulmonary morbidity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364228

28 July 2018

Phase I study of docetaxel with concomitant thoracic radiation therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364228

28 July 2018

Concurrent daily carboplatin and accelerated hyperfractionated thoracic radiotherapy in locally advanced nonsmall cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364228

28 July 2018

Radiosensitizing nucleosides

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364228

28 July 2018

Continuous carboplatin infusion during 6 weeks' radiotherapy in locally inoperable non-small-cell lung cancer: a phase I and pharmacokinetic study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364228

28 July 2018

Carboplatin as a potentiator of radiation therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364228

28 July 2018

A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364228

28 July 2018

Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364228

28 July 2018

Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. A randomized, phase III trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364228

28 July 2018

Taxol sensitizes human astrocytoma cells to radiation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364228

28 July 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6600464

21 January 2018

Phase I/II study of weekly irinotecan and concurrent radiation therapy for locally advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6600464

21 January 2018

Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6600464

21 January 2018

Phase II trial of daily low-dose carboplatin and thoracic radiotherapy in elderly patients with locally advanced non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12177791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inoperable non-small cell lung cancer: radiation with or without chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/12177791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12177791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12177791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12177791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12177791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12177791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paclitaxel in combination chemotherapy with radiotherapy in patients with unresectable stage III non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12177791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: a randomized study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12177791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paclitaxel enhances in vitro radiosensitivity of squamous carcinoma cell lines of the head and neck

1 reference

https://pubmed.ncbi.nlm.nih.gov/12177791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gemcitabine plus radiotherapy for non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12177791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology

1 reference

https://pubmed.ncbi.nlm.nih.gov/12177791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predicting radiation response

1 reference

https://pubmed.ncbi.nlm.nih.gov/12177791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Physical and biological predictors of changes in whole-lung function following thoracic irradiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/12177791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of paclitaxel as a radiation sensitizer in the treatment of mesothelioma and non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12177791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of weekly paclitaxel and concurrent radiation therapy for locally advanced non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12177791

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.BJC.6600464

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33343743&oldid=2195264779"